Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 66 entries
Sorted by: Best Match Show Resources per page
"Genetics of male infertility".

Best practice & research. Clinical endocrinology & metabolism

Flannigan R.
PMID: 33622654
Best Pract Res Clin Endocrinol Metab. 2020 Dec;34(6):101482. doi: 10.1016/j.beem.2020.101482. Epub 2020 Dec 26.

No abstract available.

Cite
Flannigan R. "Genetics of male infertility". Best Pract Res Clin Endocrinol Metab. 2020;34(6):101482doi: 10.1016/j.beem.2020.101482.
Flannigan, R. (2020). "Genetics of male infertility". Best practice & research. Clinical endocrinology & metabolism, 34(6), 101482. https://doi.org/10.1016/j.beem.2020.101482
Flannigan, Ryan. ""Genetics of male infertility"." Best practice & research. Clinical endocrinology & metabolism vol. 34,6 (2020): 101482. doi: https://doi.org/10.1016/j.beem.2020.101482
Flannigan R. "Genetics of male infertility". Best Pract Res Clin Endocrinol Metab. 2020 Dec;34(6):101482. doi: 10.1016/j.beem.2020.101482. Epub 2020 Dec 26. PMID: 33622654.
Copy Download .nbib Format: NLM
Hormone therapy for menopause and premature ovarian insufficiency.

Best practice & research. Clinical endocrinology & metabolism

Lambrinoudaki I, Paschou SA.
PMID: 34794893
Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101597. doi: 10.1016/j.beem.2021.101597. Epub 2021 Nov 10.

No abstract available.

Cite
Lambrinoudaki I, Paschou SA. Hormone therapy for menopause and premature ovarian insufficiency. Best Pract Res Clin Endocrinol Metab. 2021;35(6):101597doi: 10.1016/j.beem.2021.101597.
Lambrinoudaki, I., & Paschou, S. A. (2021). Hormone therapy for menopause and premature ovarian insufficiency. Best practice & research. Clinical endocrinology & metabolism, 35(6), 101597. https://doi.org/10.1016/j.beem.2021.101597
Lambrinoudaki, Irene, and Paschou, Stavroula A. "Hormone therapy for menopause and premature ovarian insufficiency." Best practice & research. Clinical endocrinology & metabolism vol. 35,6 (2021): 101597. doi: https://doi.org/10.1016/j.beem.2021.101597
Lambrinoudaki I, Paschou SA. Hormone therapy for menopause and premature ovarian insufficiency. Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101597. doi: 10.1016/j.beem.2021.101597. Epub 2021 Nov 10. PMID: 34794893.
Copy Download .nbib Format: NLM
Paraneoplastic autoimmune hypophysitis: An emerging concept.

Best practice & research. Clinical endocrinology & metabolism

Bando H, Kanie K, Takahashi Y.
PMID: 34876362
Best Pract Res Clin Endocrinol Metab. 2021 Nov 25;101601. doi: 10.1016/j.beem.2021.101601. Epub 2021 Nov 25.

Pituitary autoimmunity is one of the principal causes of hypopituitarism. Additionally, hypophysitis is one of the immune-related adverse events associated with immunotherapy. Recent case-oriented research has revealed a novel type of autoimmune hypophysitis, anti-PIT-1 hypophysitis, related to isolated adrenocorticotropic...

Cite
Bando H, Kanie K, Takahashi Y. Paraneoplastic autoimmune hypophysitis: An emerging concept. Best Pract Res Clin Endocrinol Metab. 2021;101601doi: 10.1016/j.beem.2021.101601.
Bando, H., Kanie, K., & Takahashi, Y. (2021). Paraneoplastic autoimmune hypophysitis: An emerging concept. Best practice & research. Clinical endocrinology & metabolism, 101601. https://doi.org/10.1016/j.beem.2021.101601
Bando, Hironori, et al. "Paraneoplastic autoimmune hypophysitis: An emerging concept." Best practice & research. Clinical endocrinology & metabolism vol. (2021): 101601. doi: https://doi.org/10.1016/j.beem.2021.101601
Bando H, Kanie K, Takahashi Y. Paraneoplastic autoimmune hypophysitis: An emerging concept. Best Pract Res Clin Endocrinol Metab. 2021 Nov 25;101601. doi: 10.1016/j.beem.2021.101601. Epub 2021 Nov 25. PMID: 34876362.
Copy Download .nbib Format: NLM
Rare forms of genetic steroidogenic defects affecting the gonads and adrenals.

Best practice & research. Clinical endocrinology & metabolism

Boettcher C, Flück CE.
PMID: 34711511
Best Pract Res Clin Endocrinol Metab. 2021 Oct 12;101593. doi: 10.1016/j.beem.2021.101593. Epub 2021 Oct 12.

Pathogenic variants have been found in all genes involved in the classic pathways of human adrenal and gonadal steroidogenesis. Depending on their function and severity, they cause characteristic disorders of corticosteroid and/or sex hormone deficiency, may result in atypical...

Cite
Boettcher C, Flück CE. Rare forms of genetic steroidogenic defects affecting the gonads and adrenals. Best Pract Res Clin Endocrinol Metab. 2021;101593doi: 10.1016/j.beem.2021.101593.
Boettcher, C., & Flück, C. E. (2021). Rare forms of genetic steroidogenic defects affecting the gonads and adrenals. Best practice & research. Clinical endocrinology & metabolism, 101593. https://doi.org/10.1016/j.beem.2021.101593
Boettcher, Claudia, and Flück, Christa E. "Rare forms of genetic steroidogenic defects affecting the gonads and adrenals." Best practice & research. Clinical endocrinology & metabolism vol. (2021): 101593. doi: https://doi.org/10.1016/j.beem.2021.101593
Boettcher C, Flück CE. Rare forms of genetic steroidogenic defects affecting the gonads and adrenals. Best Pract Res Clin Endocrinol Metab. 2021 Oct 12;101593. doi: 10.1016/j.beem.2021.101593. Epub 2021 Oct 12. PMID: 34711511.
Copy Download .nbib Format: NLM
The role of hormone therapy in urogenital health after menopause.

Best practice & research. Clinical endocrinology & metabolism

Nappi RE, Cucinella L, Martini E, Cassani C.
PMID: 34711512
Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101595. doi: 10.1016/j.beem.2021.101595. Epub 2021 Oct 12.

Menopause represents an endocrine challenge to urogenital health, as oestrogens deprivation and androgens decline significantly contributes to age-related involution of vulvovaginal tissues and lower urinary tract. Genitourinary syndrome of menopause (GSM) is a clinical entity including the chronic and...

Cite
Nappi RE, Cucinella L, Martini E, et al. The role of hormone therapy in urogenital health after menopause. Best Pract Res Clin Endocrinol Metab. 2021;35(6):101595doi: 10.1016/j.beem.2021.101595.
Nappi, R. E., Cucinella, L., Martini, E., & Cassani, C. (2021). The role of hormone therapy in urogenital health after menopause. Best practice & research. Clinical endocrinology & metabolism, 35(6), 101595. https://doi.org/10.1016/j.beem.2021.101595
Nappi, Rossella E, et al. "The role of hormone therapy in urogenital health after menopause." Best practice & research. Clinical endocrinology & metabolism vol. 35,6 (2021): 101595. doi: https://doi.org/10.1016/j.beem.2021.101595
Nappi RE, Cucinella L, Martini E, Cassani C. The role of hormone therapy in urogenital health after menopause. Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101595. doi: 10.1016/j.beem.2021.101595. Epub 2021 Oct 12. PMID: 34711512.
Copy Download .nbib Format: NLM
Therapeutic effects of androgens for cachexia.

Best practice & research. Clinical endocrinology & metabolism

Giovanelli L, Quinton R.
PMID: 34801415
Best Pract Res Clin Endocrinol Metab. 2021 Nov 10;101598. doi: 10.1016/j.beem.2021.101598. Epub 2021 Nov 10.

Cachexia is a complex wasting syndrome, accompanying a variety of end-stage chronic diseases, such as cancer, heart failure and human immunodeficiency virus (HIV) infection/acquired immunodeficiency syndrome (AIDS). It significantly affects patients' quality of life and survival. Multiple therapeutic approaches...

Cite
Giovanelli L, Quinton R. Therapeutic effects of androgens for cachexia. Best Pract Res Clin Endocrinol Metab. 2021;101598doi: 10.1016/j.beem.2021.101598.
Giovanelli, L., & Quinton, R. (2021). Therapeutic effects of androgens for cachexia. Best practice & research. Clinical endocrinology & metabolism, 101598. https://doi.org/10.1016/j.beem.2021.101598
Giovanelli, Luca, and Quinton, Richard. "Therapeutic effects of androgens for cachexia." Best practice & research. Clinical endocrinology & metabolism vol. (2021): 101598. doi: https://doi.org/10.1016/j.beem.2021.101598
Giovanelli L, Quinton R. Therapeutic effects of androgens for cachexia. Best Pract Res Clin Endocrinol Metab. 2021 Nov 10;101598. doi: 10.1016/j.beem.2021.101598. Epub 2021 Nov 10. PMID: 34801415.
Copy Download .nbib Format: NLM
Menopausal hormone therapy and breast cancer risk.

Best practice & research. Clinical endocrinology & metabolism

Rozenberg S, Di Pietrantonio V, Vandromme J, Gilles C.
PMID: 34535397
Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101577. doi: 10.1016/j.beem.2021.101577. Epub 2021 Sep 10.

This narrative review analyses the customization of Menopause Hormone Therapy in the context of breast cancer risk in women with premature ovarian insufficiency (POI) and with menopause at a normal age. Women with Idiopathic POI, FMR-1 premutation or Turner...

Cite
Rozenberg S, Di Pietrantonio V, Vandromme J, et al. Menopausal hormone therapy and breast cancer risk. Best Pract Res Clin Endocrinol Metab. 2021;35(6):101577doi: 10.1016/j.beem.2021.101577.
Rozenberg, S., Di Pietrantonio, V., Vandromme, J., & Gilles, C. (2021). Menopausal hormone therapy and breast cancer risk. Best practice & research. Clinical endocrinology & metabolism, 35(6), 101577. https://doi.org/10.1016/j.beem.2021.101577
Rozenberg, Serge, et al. "Menopausal hormone therapy and breast cancer risk." Best practice & research. Clinical endocrinology & metabolism vol. 35,6 (2021): 101577. doi: https://doi.org/10.1016/j.beem.2021.101577
Rozenberg S, Di Pietrantonio V, Vandromme J, Gilles C. Menopausal hormone therapy and breast cancer risk. Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101577. doi: 10.1016/j.beem.2021.101577. Epub 2021 Sep 10. PMID: 34535397.
Copy Download .nbib Format: NLM
Preface - microRNAs in endocrine cancers and metabolism.

Best practice & research. Clinical endocrinology & metabolism

Krützfeldt J.
PMID: 27923449
Best Pract Res Clin Endocrinol Metab. 2016 Oct;30(5):549. doi: 10.1016/j.beem.2016.11.011.

No abstract available.

Cite
Krützfeldt J. Preface - microRNAs in endocrine cancers and metabolism. Best Pract Res Clin Endocrinol Metab. 2016;30(5):549doi: 10.1016/j.beem.2016.11.011.
Krützfeldt, J. (2016). Preface - microRNAs in endocrine cancers and metabolism. Best practice & research. Clinical endocrinology & metabolism, 30(5), 549. https://doi.org/10.1016/j.beem.2016.11.011
Krützfeldt, Jan. "Preface - microRNAs in endocrine cancers and metabolism." Best practice & research. Clinical endocrinology & metabolism vol. 30,5 (2016): 549. doi: https://doi.org/10.1016/j.beem.2016.11.011
Krützfeldt J. Preface - microRNAs in endocrine cancers and metabolism. Best Pract Res Clin Endocrinol Metab. 2016 Oct;30(5):549. doi: 10.1016/j.beem.2016.11.011. PMID: 27923449.
Copy Download .nbib Format: NLM
Menopausal hormone therapy in women with medical conditions.

Best practice & research. Clinical endocrinology & metabolism

Kapoor E, Kling JM, Lobo AS, Faubion SS.
PMID: 34583890
Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101578. doi: 10.1016/j.beem.2021.101578. Epub 2021 Sep 10.

Hormone therapy is the most effective treatment for menopause-related symptoms. Current evidence supports its use in young healthy postmenopausal women under the age of 60 years, and within 10 years of menopause, with benefits typically outweighing risks. However, decision...

Cite
Kapoor E, Kling JM, Lobo AS, et al. Menopausal hormone therapy in women with medical conditions. Best Pract Res Clin Endocrinol Metab. 2021;35(6):101578doi: 10.1016/j.beem.2021.101578.
Kapoor, E., Kling, J. M., Lobo, A. S., & Faubion, S. S. (2021). Menopausal hormone therapy in women with medical conditions. Best practice & research. Clinical endocrinology & metabolism, 35(6), 101578. https://doi.org/10.1016/j.beem.2021.101578
Kapoor, Ekta, et al. "Menopausal hormone therapy in women with medical conditions." Best practice & research. Clinical endocrinology & metabolism vol. 35,6 (2021): 101578. doi: https://doi.org/10.1016/j.beem.2021.101578
Kapoor E, Kling JM, Lobo AS, Faubion SS. Menopausal hormone therapy in women with medical conditions. Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101578. doi: 10.1016/j.beem.2021.101578. Epub 2021 Sep 10. PMID: 34583890; PMCID: PMC8648973.
Copy Download .nbib Format: NLM
Menopausal hormone therapy in women with benign gynaecological conditions and cancer.

Best practice & research. Clinical endocrinology & metabolism

Brennan A, Rees M.
PMID: 34686433
Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101575. doi: 10.1016/j.beem.2021.101575. Epub 2021 Sep 10.

The efficacy of menopausal hormone therapy for bothersome menopausal symptoms is well established. However, there are a range of benign and malignant gynaecological conditions that pose a challenge in managing menopausal symptoms. Their hormone-dependent nature either raises concerns about...

Cite
Brennan A, Rees M. Menopausal hormone therapy in women with benign gynaecological conditions and cancer. Best Pract Res Clin Endocrinol Metab. 2021;35(6):101575doi: 10.1016/j.beem.2021.101575.
Brennan, A., & Rees, M. (2021). Menopausal hormone therapy in women with benign gynaecological conditions and cancer. Best practice & research. Clinical endocrinology & metabolism, 35(6), 101575. https://doi.org/10.1016/j.beem.2021.101575
Brennan, Annabelle, and Rees, Margaret. "Menopausal hormone therapy in women with benign gynaecological conditions and cancer." Best practice & research. Clinical endocrinology & metabolism vol. 35,6 (2021): 101575. doi: https://doi.org/10.1016/j.beem.2021.101575
Brennan A, Rees M. Menopausal hormone therapy in women with benign gynaecological conditions and cancer. Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101575. doi: 10.1016/j.beem.2021.101575. Epub 2021 Sep 10. PMID: 34686433.
Copy Download .nbib Format: NLM
Diabetes and the heart: a complex interaction.

Best practice & research. Clinical endocrinology & metabolism

Roffi M, Eberli FR.
PMID: 19520303
Best Pract Res Clin Endocrinol Metab. 2009 Jun;23(3):vii-viii. doi: 10.1016/j.beem.2009.01.001.

No abstract available.

Cite
Roffi M, Eberli FR. Diabetes and the heart: a complex interaction. Best Pract Res Clin Endocrinol Metab. 2009;23(3):vii-viiidoi: 10.1016/j.beem.2009.01.001.
Roffi, M., & Eberli, F. R. (2009). Diabetes and the heart: a complex interaction. Best practice & research. Clinical endocrinology & metabolism, 23(3), vii-viii. https://doi.org/10.1016/j.beem.2009.01.001
Roffi, Marco, and Eberli, Franz R. "Diabetes and the heart: a complex interaction." Best practice & research. Clinical endocrinology & metabolism vol. 23,3 (2009): vii-viii. doi: https://doi.org/10.1016/j.beem.2009.01.001
Roffi M, Eberli FR. Diabetes and the heart: a complex interaction. Best Pract Res Clin Endocrinol Metab. 2009 Jun;23(3):vii-viii. doi: 10.1016/j.beem.2009.01.001. PMID: 19520303.
Copy Download .nbib Format: NLM
Preface - Part 2: Circadian and endocrine rhythms.

Best practice & research. Clinical endocrinology & metabolism

Kalsbeek A, Fliers E.
PMID: 29224664
Best Pract Res Clin Endocrinol Metab. 2017 Dec;31(6):519. doi: 10.1016/j.beem.2017.11.006.

No abstract available.

Cite
Kalsbeek A, Fliers E. Preface - Part 2: Circadian and endocrine rhythms. Best Pract Res Clin Endocrinol Metab. 2017;31(6):519doi: 10.1016/j.beem.2017.11.006.
Kalsbeek, A., & Fliers, E. (2017). Preface - Part 2: Circadian and endocrine rhythms. Best practice & research. Clinical endocrinology & metabolism, 31(6), 519. https://doi.org/10.1016/j.beem.2017.11.006
Kalsbeek, Andries, and Fliers, Eric. "Preface - Part 2: Circadian and endocrine rhythms." Best practice & research. Clinical endocrinology & metabolism vol. 31,6 (2017): 519. doi: https://doi.org/10.1016/j.beem.2017.11.006
Kalsbeek A, Fliers E. Preface - Part 2: Circadian and endocrine rhythms. Best Pract Res Clin Endocrinol Metab. 2017 Dec;31(6):519. doi: 10.1016/j.beem.2017.11.006. PMID: 29224664.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 66 entries